Search
| Leader | 00000nz a2200037n 45 0 | ||
|---|---|---|---|
| 001 | WKP|Q58883283 (VIAF cluster) (Authority/Source Record) | ||
| 003 | WKP | ||
| 005 | 20241121000332.0 | ||
| 008 | 241121nneanz||abbn n and d | ||
| 035 | ‡a (WKP)Q58883283 | ||
| 024 | ‡a 0000-0002-9113-8691 ‡2 orcid | ||
| 035 | ‡a (OCoLC)Q58883283 | ||
| 100 | 0 | ‡a Duncan J Stewart ‡9 ast | |
| 400 | 0 | ‡a ডানকান জে স্টুয়ার্ট ‡9 bn | |
| 400 | 0 | ‡a Duncan J Stewart ‡c researcher ORCID ID = 0000-0002-9113-8691 ‡9 en | |
| 400 | 0 | ‡a Duncan J Stewart ‡c onderzoeker ‡9 nl | |
| 670 | ‡a Author's Efficacy of treprostinil in the SU5416-hypoxia model of severe pulmonary arterial hypertension: haemodynamic benefits are not associated with improvements in arterial remodelling | ||
| 670 | ‡a Author's Emphysema Is-at the Most-Only a Mild Phenotype in the Sugen/Hypoxia Rat Model of Pulmonary Arterial Hypertension | ||
| 670 | ‡a Author's Evaluating mesenchymal stem cell therapy for sepsis with preclinical meta-analyses prior to initiating a first-in-human trial | ||
| 670 | ‡a Author's Increased Expression of Vascular Endothelial Growth Factor-D Following Brain Injury | ||
| 670 | ‡a Author's Marked Strain-Specific Differences in the SU5416 Rat Model of Severe Pulmonary Arterial Hypertension. | ||
| 670 | ‡a Author's Safety and Efficacy of Adult Stem Cell Therapy for Acute Myocardial Infarction and Ischemic Heart Failure | ||
| 670 | ‡a Author's Safety and Efficacy of Adult Stem Cell Therapy for Acute Myocardial Infarction and Ischemic Heart Failure (SafeCell Heart): A Systematic Review and Meta-Analysis. | ||
| 670 | ‡a Author's Strategies for controlling egress of therapeutic cells from hydrogel microcapsules | ||
| 670 | ‡a Author's Thawed Mesenchymal Stem Cell Product Shows Comparable Immunomodulatory Potency to Cultured Cells In Vitro and in Polymicrobial Septic Animals | ||
| 670 | ‡a Author's The Adult Sprague-Dawley Sugen-Hypoxia Rat Is Still "the One:" A Model of Group 1 Pulmonary Hypertension: Reply to Le Cras and Abman | ||
| 670 | ‡a Author's Vascular contributions to 16p11.2 deletion autism syndrome modeled in mice | ||
| 909 | ‡a (orcid) 0000000291138691 ‡9 1 | ||
| 919 | ‡a adultspraguedawleysugenhypoxiaratisstillthe1amodelofgroup1pulmonaryhypertensionreplytolecrasandabman ‡A The Adult Sprague-Dawley Sugen-Hypoxia Rat Is Still "the One:" A Model of Group 1 Pulmonary Hypertension: Reply to Le Cras and Abman ‡9 1 | ||
| 919 | ‡a thawedmesenchymalstemcellproductshowscomparableimmunomodulatorypotencytoculturedcellsinvitroandinpolymicrobialsepticanimals ‡A Thawed Mesenchymal Stem Cell Product Shows Comparable Immunomodulatory Potency to Cultured Cells In Vitro and in Polymicrobial Septic Animals ‡9 1 | ||
| 919 | ‡a strategiesforcontrollingegressoftherapeuticcellsfromhydrogelmicrocapsules ‡A Strategies for controlling egress of therapeutic cells from hydrogel microcapsules ‡9 1 | ||
| 919 | ‡a safetyandefficacyofadultstemcelltherapyforacutemyocardialinfarctionandischemicheartfailuresafecellheartasystematicreviewandmetaanalysis ‡A Safety and Efficacy of Adult Stem Cell Therapy for Acute Myocardial Infarction and Ischemic Heart Failure (SafeCell Heart): A Systematic Review and Meta-Analysis. ‡9 1 | ||
| 919 | ‡a safetyandefficacyofadultstemcelltherapyforacutemyocardialinfarctionandischemicheartfailure ‡A Safety and Efficacy of Adult Stem Cell Therapy for Acute Myocardial Infarction and Ischemic Heart Failure ‡9 1 | ||
| 919 | ‡a markedstrainspecificdifferencesinthesu5416ratmodelofseverepulmonaryarterialhypertension ‡A Marked Strain-Specific Differences in the SU5416 Rat Model of Severe Pulmonary Arterial Hypertension. ‡9 1 | ||
| 919 | ‡a increasedexpressionofvascularendothelialgrowthfactor500followingbraininjury ‡A Increased Expression of Vascular Endothelial Growth Factor-D Following Brain Injury ‡9 1 | ||
| 919 | ‡a evaluatingmesenchymalstemcelltherapyforsepsiswithpreclinicalmetaanalysespriortoinitiatinga1inhumantrial ‡A Evaluating mesenchymal stem cell therapy for sepsis with preclinical meta-analyses prior to initiating a first-in-human trial ‡9 1 | ||
| 919 | ‡a emphysemaisatthemostonlyamildphenotypeinthesugenhypoxiaratmodelofpulmonaryarterialhypertension ‡A Emphysema Is-at the Most-Only a Mild Phenotype in the Sugen/Hypoxia Rat Model of Pulmonary Arterial Hypertension ‡9 1 | ||
| 919 | ‡a efficacyoftreprostinilinthesu5416hypoxiamodelofseverepulmonaryarterialhypertensionhaemodynamicbenefitsarenotassociatedwithimprovementsinarterialremodelling ‡A Efficacy of treprostinil in the SU5416-hypoxia model of severe pulmonary arterial hypertension: haemodynamic benefits are not associated with improvements in arterial remodelling ‡9 1 | ||
| 919 | ‡a vascularcontributionsto16p112deletionautismsyndromemodeledinmice ‡A Vascular contributions to 16p11.2 deletion autism syndrome modeled in mice ‡9 1 | ||
| 996 | ‡2 LC|no2007018669 | ||
| 996 | ‡2 CAOONL|ncf11303334 | ||
| 996 | ‡2 J9U|987007426329505171 | ||
| 996 | ‡2 LC|nb2020003473 | ||
| 996 | ‡2 ISNI|0000000050761458 | ||
| 996 | ‡2 ISNI|0000000021826208 | ||
| 996 | ‡2 ISNI|0000000374099093 | ||
| 996 | ‡2 CAOONL|ncf10051093 | ||
| 996 | ‡2 CAOONL|ncf11392914 | ||
| 996 | ‡2 N6I|vtls002112700 | ||
| 996 | ‡2 ISNI|0000000395889780 | ||
| 996 | ‡2 LC|n 87832635 | ||
| 996 | ‡2 BIBSYS|1080970 | ||
| 996 | ‡2 J9U|987007357377105171 | ||
| 996 | ‡2 NTA|070095086 | ||
| 996 | ‡2 LC|no 91002004 | ||
| 996 | ‡2 LC|nb2015004706 | ||
| 996 | ‡2 BIBSYS|90946357 | ||
| 996 | ‡2 LC|n 92105006 | ||
| 996 | ‡2 LC|no2024060523 | ||
| 996 | ‡2 PTBNP|120680 | ||
| 996 | ‡2 SUDOC|225644886 | ||
| 996 | ‡2 ISNI|0000000051675367 | ||
| 996 | ‡2 LC|n 2009161315 | ||
| 996 | ‡2 LC|n 77013631 | ||
| 996 | ‡2 B2Q|0000326077 | ||
| 996 | ‡2 DNB|115734304X | ||
| 996 | ‡2 LC|nb2016017441 | ||
| 996 | ‡2 ISNI|0000000451496237 | ||
| 996 | ‡2 LC|n 2011013762 | ||
| 996 | ‡2 RERO|A013719503 | ||
| 996 | ‡2 JPG|500085020 | ||
| 996 | ‡2 LC|no2019015536 | ||
| 996 | ‡2 LC|no 98116016 | ||
| 996 | ‡2 SUDOC|165709618 | ||
| 996 | ‡2 ISNI|0000000362961627 | ||
| 996 | ‡2 LC|nb2011005059 | ||
| 996 | ‡2 DNB|1315945746 | ||
| 996 | ‡2 ISNI|0000000118556507 | ||
| 996 | ‡2 N6I|vtls000853781 | ||
| 996 | ‡2 LC|n 2013042480 | ||
| 996 | ‡2 SUDOC|224267159 | ||
| 996 | ‡2 ISNI|0000000134838328 | ||
| 996 | ‡2 ISNI|0000000068685924 | ||
| 996 | ‡2 LC|no2023000829 | ||
| 996 | ‡2 BNF|10609959 | ||
| 996 | ‡2 NTA|074460439 | ||
| 996 | ‡2 CAOONL|ncf10015933 | ||
| 996 | ‡2 JPG|500086702 | ||
| 996 | ‡2 CAOONL|ncf10028206 | ||
| 996 | ‡2 NTA|072745045 | ||
| 996 | ‡2 RERO|A022797015 | ||
| 996 | ‡2 LC|no2008184455 | ||
| 996 | ‡2 ISNI|0000000041412440 | ||
| 996 | ‡2 LC|no2023038338 | ||
| 996 | ‡2 LC|n 78037574 | ||
| 996 | ‡2 RERO|A009125077 | ||
| 996 | ‡2 SUDOC|238673995 | ||
| 996 | ‡2 SUDOC|085844578 | ||
| 996 | ‡2 CAOONL|ncf10937716 | ||
| 996 | ‡2 ISNI|000000005802003X | ||
| 996 | ‡2 ISNI|0000000115184584 | ||
| 996 | ‡2 ISNI|0000000496361088 | ||
| 996 | ‡2 RERO|A009198617 | ||
| 996 | ‡2 LC|no2022055647 | ||
| 996 | ‡2 J9U|987007272599505171 | ||
| 996 | ‡2 LC|nb2023008825 | ||
| 996 | ‡2 LC|no 94021029 | ||
| 996 | ‡2 LC|no2020128484 | ||
| 996 | ‡2 DNB|132783606 | ||
| 996 | ‡2 LC|n 85089927 | ||
| 996 | ‡2 SUDOC|083291644 | ||
| 996 | ‡2 ISNI|0000000023493670 | ||
| 996 | ‡2 JPG|500103604 | ||
| 996 | ‡2 LC|nr 93037603 | ||
| 996 | ‡2 CAOONL|ncf10203519 | ||
| 996 | ‡2 ISNI|0000000048615777 | ||
| 996 | ‡2 LC|no2003121548 | ||
| 996 | ‡2 LC|n 82107341 | ||
| 996 | ‡2 LC|n 86806849 | ||
| 996 | ‡2 BIBSYS|66420 | ||
| 996 | ‡2 LC|nr 93012913 | ||
| 996 | ‡2 DE633|pe51011895 | ||
| 996 | ‡2 ISNI|0000000499954006 | ||
| 996 | ‡2 BIBSYS|90670877 | ||
| 997 | ‡a 0 0 lived 0 0 ‡9 1 |
